Xiangling Wang, MD
Clinical Genetics (M.D.) · Cleveland, OHNPI 1366889438
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,762 of the $4,237 with a category attached, or 88.8%. 6 manufacturers reported payments, led by Sanofi at 56.9% of the total. Reporting peaked in 2021 at $3,762 and has fallen 90.7% since, to $348 in 2025.
Across 9 payments — averaging $470.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$2K
- Alnylam Pharmaceuticals Inc.$1K
- Sanofi US Services Inc.$139
- Vertex$135
- AstraZeneca$126
- Novartis$74
Across 10 payments — averaging $4360.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amicus Therapeutics, Inc.$25K
- Sanofi$18K
- Vertex$827
What the payments were for
- Consulting fees$3,76289%
- Food & beverage$47511%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 1 | $2,412 |
| Alnylam Pharmaceuticals Inc. | 1 | $1,350 |
| Sanofi US Services Inc. | 1 | $139 |
| Vertex | 4 | $135 |
| AstraZeneca | 1 | $126 |
| Novartis | 1 | $74 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,237 in reported general payments places this provider in the 75th percentile of 42 clinical genetics (m.d.) providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical genetics (m.d.) in Cleveland
- Angelika ErwinCleveland$225K
- Laura KonczalCleveland$47K
- Rocio MoranCleveland$1K
- Jirat ChenbhanichCleveland$384
- Charis EngCleveland$321
- Jessica OgawaCleveland$184
- Aditi YadavCleveland$168
- Aditi ParikhCleveland$94
- Kirkland WilsonCleveland$35
- Adnan AlsadahCleveland$33
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.